Masimo | MASI - Ebit


Masimo reported $83.7M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Abbott USD 2.54B 358M Dec/2025
Accuray USD 11.38M 12.71M Sep/2024
Align Technology USD 224.71M 40.06M Dec/2025
AngioDynamics USD -4.05M 1.54M Feb/2025
AtriCure USD 2.49M 2.28M Dec/2025
Avanos Medical USD 18.97M 72.63M Sep/2025
Baxter International USD -214.2M 415.4M Dec/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Boston Scientific USD 1.24B 203M Dec/2025
Dexcom USD 323M 80.5M Dec/2025
Edwards Lifesciences USD 370.3M 54.8M Dec/2025
General Electric Aerospace USD 1.68B 429M Dec/2025
Globus Medical USD -117.52M 8.43M Sep/2025
Haemonetics USD 67.4M 13.71M Dec/2025
Insulet USD 146.3M 28.6M Dec/2025
Integra LifeSciences USD 11.76M 521.67M Sep/2025
Intuitive Surgical USD 865.3M 97.5M Dec/2025
Masimo USD 83.7M 19.2M Sep/2025
Medtronic USD 1.74B 40M Dec/2025
Orthofix International USD -18.9M 6.01M Sep/2024
Owens Minor USD 61.29M 34.09M Mar/2025
ResMed USD 497.6M 35.25M Dec/2025
Steris USD 278M 7.1M Dec/2025
Stryker USD 1.97B 609M Dec/2025
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD 112.65M 44.3M Sep/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
Zimmer Biomet Holdings USD 302.9M 35.4M Dec/2025